Translational Science & Applied Innovation

Innovation Built on
Deep Scientific Capability.

HH Global Holdings' innovation programme is the output of deep translational science, evidence generation and regulatory understanding. Where the science demands a new platform, methodology or framework, we build it: rapid diagnostics that translate laboratory rigour into point-of-care use, assay platforms that accelerate biomarker discovery, and bioinformatics architectures that turn complex data into regulatory-grade evidence. Each programme below is grounded in a specific scientific problem and a defined evidentiary requirement.

Innovation Domains

Diagnostics & Therapeutics

Rapid diagnostic and therapeutic technologies enabling point-of-care detection and intervention across human, animal, and environmental health applications.

Biotechnology Platforms

Assay and translational platforms enabling high-throughput biomarker identification, drug discovery, and translational development.

Data & Health Intelligence

Data-driven systems and analytical approaches converting complex datasets into defensible insights across human, animal, and environmental health domains.

Selected Examples

Illustrative of the work in each category, not the sole focus areas within them.

Diagnostics & Therapeutics

  • Multiplex Lateral Flow Test (UK Patent-Pending), True multiplexing on a single strip using microarray spotted technology. Can spot 20-60 individual proteins or antibodies onto a single flow cell, detect both proteins AND antibodies in a single test. One of the first platforms to enable dual detection. Optimised for different porosities and incubation times per target.

Biotechnology Platforms

  • Extended Patent Library, Active pipeline of patent applications spanning animal health diagnostics, agricultural testing platforms, and agri-environmental monitoring systems. Sector-specific applications of core technologies.

Data & Health Intelligence

  • One Health Data Integration, Integrated analytical framework bridging human, animal, and environmental health data. Epidemiological modelling, One Health pathway analysis, integrated risk assessment.
  • Evidence Generation Workflows, Systematic approaches to evidence generation, validation, and regulatory documentation. Designed to support rapid translation from bench to bedside to regulation.